Mirnext Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Out of Business

  • Employees
  • 17

Employees

  • Latest Deal Type
  • Out of Business

Mirnext General Information

Description

Developer of multi-marker tests designed to treat cardiovascular diseases. The company's miRNA based cardiovascular tests improve diagnostic routines and prognostic clinical management of heart failure, enabling medical practitioners to improve diagnosis and clinical management of patients entering the clinic with symptoms of heart failure.

Contact Information

Website
www.mirnext.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Meibergdreef 5
  • 1105 AZ Amsterdam
  • Netherlands
+31 020
Primary Industry
Drug Discovery
Other Industries
Other Healthcare Technology Systems
Biotechnology
Vertical(s)
Corporate Office
  • Meibergdreef 5
  • 1105 AZ Amsterdam
  • Netherlands
+31 020

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Mirnext Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-Jan-2019 Completed Out of Business
1. Early Stage VC 01-Jan-2012 Completed Startup
To view Mirnext’s complete valuation and funding history, request access »

Mirnext Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of multi-marker tests designed to treat cardiovascular diseases. The company's miRNA based cardiovascular test
Drug Discovery
Amsterdam, Netherlands
17 As of 2013

Montreal, Canada
 

West Jordan, UT
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Mirnext Competitors (6)

One of Mirnext’s 6 competitors is DalCor Pharmaceuticals, a Venture Capital-Backed company based in Montreal, Canada.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
DalCor Pharmaceuticals Venture Capital-Backed Montreal, Canada
InCarda Therapeutics Venture Capital-Backed West Jordan, UT
Cytokinetics Formerly VC-backed South San Francisco, CA
Critical Diagnostics Formerly VC-backed San Diego, CA
Tenaya Therapeutics Formerly VC-backed South San Francisco, CA
To view Mirnext’s complete competitors history, request access »

Mirnext Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Mirnext FAQs

  • When was Mirnext founded?

    Mirnext was founded in 2012.

  • Where is Mirnext headquartered?

    Mirnext is headquartered in Amsterdam, Netherlands.

  • What is the size of Mirnext?

    Mirnext has 17 total employees.

  • What industry is Mirnext in?

    Mirnext’s primary industry is Drug Discovery.

  • Is Mirnext a private or public company?

    Mirnext is a Private company.

  • What is Mirnext’s current revenue?

    The current revenue for Mirnext is .

  • Who are Mirnext’s competitors?

    DalCor Pharmaceuticals, InCarda Therapeutics, Cytokinetics, Critical Diagnostics, and Tenaya Therapeutics are some of the 6 competitors of Mirnext.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process